Processa Pharmaceuticals's total assets for Q1 2025 were $4.81M, an increase of 48.94% from the previous quarter. PCSA total liabilities were $1.28M for the fiscal quarter, a -16.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.